What component is NOT included in the management of cystic fibrosis?

In the management of cystic fibrosis, many components focus on addressing the various complications arising from the disease. Pulmonary therapy is crucial as it aims to maintain clear airways and a healthy lung function through methods like chest physiotherapy and inhalation treatments. Pancreatic enzyme replacement is also essential for managing digestive issues caused by the thick mucus obstructing the pancreas, which leads to malabsorption of nutrients. Additionally, antibiotic therapy plays a role in managing respiratory infections that are common in individuals with cystic fibrosis, particularly since they are at increased risk for bacterial infections in the lungs.

In contrast, immunoglobulin therapy is not a standard part of cystic fibrosis management. While immunoglobulins may be used for other conditions, their use in cystic fibrosis does not address the primary issues of airway clearance, digestion, or infection management associated with the disease. Thus, it is not routinely included in the comprehensive treatment plan for cystic fibrosis, making it the correct choice for the component not included in its management.